- Home
- VRDN vs EVV Comparison
VRDN vs EVV Comparison
Compare VRDN & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- EVV
- Stock Information
- Founded
- VRDN 2006
- EVV 2003
- Country
- VRDN United States
- EVV United States
- Employees
- VRDN N/A
- EVV N/A
- Industry
- VRDN Medical Specialities
- EVV Finance/Investors Services
- Sector
- VRDN Health Care
- EVV Finance
- Exchange
- VRDN Nasdaq
- EVV Nasdaq
- Market Cap
- VRDN 1.0B
- EVV 1.2B
- IPO Year
- VRDN N/A
- EVV N/A
- Fundamental
- Price
- VRDN $14.04
- EVV $10.01
- Analyst Decision
- VRDN Strong Buy
- EVV
- Analyst Count
- VRDN 12
- EVV 0
- Target Price
- VRDN $38.50
- EVV N/A
- AVG Volume (30 Days)
- VRDN 838.2K
- EVV 323.7K
- Earning Date
- VRDN 05-06-2025
- EVV 01-01-0001
- Dividend Yield
- VRDN N/A
- EVV 9.66%
- EPS Growth
- VRDN N/A
- EVV N/A
- EPS
- VRDN N/A
- EVV N/A
- Revenue
- VRDN $302,000.00
- EVV N/A
- Revenue This Year
- VRDN N/A
- EVV N/A
- Revenue Next Year
- VRDN $21,976.14
- EVV N/A
- P/E Ratio
- VRDN N/A
- EVV N/A
- Revenue Growth
- VRDN 4.86
- EVV N/A
- 52 Week Low
- VRDN $9.90
- EVV $8.52
- 52 Week High
- VRDN $27.20
- EVV $10.07
- Technical
- Relative Strength Index (RSI)
- VRDN 55.33
- EVV 58.80
- Support Level
- VRDN $13.37
- EVV $9.93
- Resistance Level
- VRDN $14.18
- EVV $9.94
- Average True Range (ATR)
- VRDN 0.67
- EVV 0.06
- MACD
- VRDN 0.12
- EVV 0.01
- Stochastic Oscillator
- VRDN 71.43
- EVV 100.00
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest
Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund may, as a secondary objective, also seek capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure among others.